Pain Control News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Robin Williams, Suicide and Shame

Robin Williams, Suicide and Shame

Odyssey Networks (Aug. 15, 2014) — The death by suicide of Robin Williams earlier this week shocked his fans around the world. It also focused attention on suicide and the discomfort we all feel about the disease that leads to it. “We’re not ashamed of having cancer, we’re not ashamed of having ALS or any other devastating disease. But there’s a lot of shame associated with emotional illness” says Rabbi Brad Hirschfield, President of Clal and Co-founder and Executive Editor of TheWidsomDaily.com. Video provided by Odyssey
Powered by NewsLook.com
FDA-Approved Sleeping Pill Not Compared To Other Drugs

FDA-Approved Sleeping Pill Not Compared To Other Drugs

Newsy (Aug. 14, 2014) — The FDA has approved Belsomra, a new kind of sleep aid that could help people fall asleep faster and stay asleep longer. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

All Pain Control News

last updated on 2014-08-20 at 6:54 am EDT

Subscribe for Free


Stay up to date with ScienceDaily's Pain Control News, delivered daily to your email inbox or RSS reader:

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Share This

via email and social networks

Subscribe for Free


Get ScienceDaily's Pain Control News, delivered daily via email or RSS:

Most Popular Stories

from the past week

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins